Skip to main content
. 2019 Apr 25;3:PO.18.00299. doi: 10.1200/PO.18.00299

FIG 3.

FIG 3.

The number of patients across the entire study successfully tested for key genomic alterations by InVisionFirst and tissue testing. EGFR, epidermal growth factor receptor.